000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102). (1st September 2005) - du Bois, A.; Schroeder, W.; Jelic, S.; Weber, B.; Sehouli, J.; Keern, J.; Priou, F.; Huober, J.; Railing, M.; Ray-Coquard, I.; Heilmann, V.; Surges, A.; et al.